Health Condition 1: null- Age â?¥ 5 years and verrucae â?¥ 3 verrucae other than anogenital verrucae were included.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with age >= 5 years and number of verrucae >= 3 on any site of the body other than anogenital verrucae were included.
Exclusion criteria
Exclusion criteria: patients on immunosuppressants/ immunomodulators, immunocompromised patients, pregnant and lactating mothers, patients on treatment for verrucae (within 4 weeks of enrollment), known cases of severe allergic reactions to local anaesthetics and patients who declined to participate were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients were categorized as follows according to the clinical response: Responder: Complete resolution of all verrucae within three months. â??Complete resolutionâ?? was defined as the restoration of normal dermatoglyphics in the treated as well as the other affected areas of skin. Non-responder: No resolution or partial resolution of verrucae (number or size) at the end of three months. Timepoint: Patients were categorized as follows according to the clinical response: Responder: Complete resolution of all verrucae within three months. â??Complete resolutionâ?? was defined as the restoration of normal dermatoglyphics in the treated as well as the other affected areas of skin. Non-responder: No resolution or partial resolution of verrucae (number or size) at the end of three months. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side-effects or recurrencesTimepoint: End of 1 year | — |
Countries
India
Contacts
HBT Medical College and Dr R N Cooper Municipal General Hospital